)
)
Denali Therapeutics Investor Relations Material
Latest events
Study Result
Denali Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Denali Therapeutics Inc
Access all reports
Denali Therapeutics, Inc. is a biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company has been operating its business since 2013.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DNLI
Country
🇺🇸 United States